ES2036593T3 - Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas. - Google Patents

Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.

Info

Publication number
ES2036593T3
ES2036593T3 ES87401327T ES87401327T ES2036593T3 ES 2036593 T3 ES2036593 T3 ES 2036593T3 ES 87401327 T ES87401327 T ES 87401327T ES 87401327 T ES87401327 T ES 87401327T ES 2036593 T3 ES2036593 T3 ES 2036593T3
Authority
ES
Spain
Prior art keywords
liposomes
inflammatory
encapsulated
compositions
steroid anti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87401327T
Other languages
English (en)
Spanish (es)
Inventor
Alan L. Weiner
Pieter R. Cullis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of ES2036593T3 publication Critical patent/ES2036593T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES87401327T 1986-06-12 1987-06-12 Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas. Expired - Lifetime ES2036593T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87358486A 1986-06-12 1986-06-12
US93415186A 1986-11-24 1986-11-24
US6118687A 1987-06-11 1987-06-11

Publications (1)

Publication Number Publication Date
ES2036593T3 true ES2036593T3 (es) 1993-06-01

Family

ID=27369998

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87401327T Expired - Lifetime ES2036593T3 (es) 1986-06-12 1987-06-12 Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.

Country Status (5)

Country Link
EP (1) EP0249561B1 (forum.php)
CA (1) CA1320130C (forum.php)
DE (1) DE3778972D1 (forum.php)
ES (1) ES2036593T3 (forum.php)
GR (1) GR3004723T3 (forum.php)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
GB2217596A (en) * 1988-04-26 1989-11-01 American Cyanamid Co Anti-arthritic liposome composition
US5133965A (en) * 1988-06-08 1992-07-28 Fountain Pharmaceuticals, Inc. Dressing material having adsorbed thereon a solvent dilution microcarrier precursor solution
US5269979A (en) * 1988-06-08 1993-12-14 Fountain Pharmaceuticals, Inc. Method for making solvent dilution microcarriers
IL90561A (en) * 1988-06-08 1993-08-18 Fountain Pharm Inc Method for making solvent dilution microcarriers
ES2071481T3 (es) * 1990-12-03 1995-06-16 Vestar Inc Prevencion de adherencias sinoviales.
DE69302677T2 (de) * 1992-02-12 1996-10-02 Janssen Cilag S P A Liposomale piroxycam formulierung
WO1993015718A1 (en) * 1992-02-12 1993-08-19 Janssen Farmaceutici S.P.A. Liposomal piroxicam formulations
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
DE69328545T2 (de) * 1993-03-24 2001-07-05 Collaborative Laboratories Inc., East Setauket Kosmetisches Verabreichungssystem für Salizylsäure und Verfahren zur Herstellung desselben
US5478819A (en) * 1993-06-23 1995-12-26 Simo Tarpila Phospholipid composition and use thereof
WO1995020944A1 (en) * 1994-02-04 1995-08-10 Scotia Lipidteknik Ab Bilayer preparations
HU221432B (en) * 1994-02-04 2002-10-28 Lipocore Holding Ab Lipophilic carrier preparations
SE518823C2 (sv) * 1994-07-12 2002-11-26 Karlshamns Lipidteknik Ab Olja-i-vatten-emulsioner
DE797432T1 (de) * 1994-02-04 1998-02-19 Scotia Lipidteknik Ab Öl-in-wasser-emulsionen
DE4420727A1 (de) * 1994-06-15 1995-12-21 Rovi Gmbh Hautfreundliche wäßrige Liposomendispersionen, enthaltend alpha-Hydroxycarbonsäuren und/oder alpha-Hydroxyketosäuren in ihrer Salzform
IT1270678B (it) * 1994-10-20 1997-05-07 Bayer Ag Liposomi al chetoprofen
DZ1965A1 (fr) * 1995-02-06 2002-07-17 Astra Ab Composition pharmaceutique nouvelle.
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
FR2742054B1 (fr) * 1995-12-06 1998-01-09 Synthelabo Compositions pharmaceutiques contenant un agent anti-inflammatoire et des ceramides vegetales
GR1003359B (el) * 1998-12-24 2000-04-10 �.�. ����������� �.�.�.�. Λιποσωμιακο νιφλουμικο οξυ - νεο διαδερμικο αντιφλεγμονωδες φαρμακο [κεφαλη ψαροτουφεκου
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
JP5846711B2 (ja) 2005-06-09 2016-01-20 メダ アーベー 炎症性疾患の治療のための方法及び組成物
CN101787059B (zh) * 2009-05-12 2014-10-15 沈阳药科大学 双半乳糖基二酰甘油酯的制备方法及其应用
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
EP2480209A1 (en) 2009-09-23 2012-08-01 Indu Javeri Methods for the preparation of liposomes comprising docetaxel
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
CN103237546B (zh) 2010-07-28 2016-06-08 生命科技公司 抗病毒的含有叠氮化物的化合物
AU2013212068B2 (en) 2012-01-26 2018-02-15 Life Technologies Corporation Methods for increasing the infectivity of viruses
CA2970917C (en) * 2014-12-15 2019-09-17 Nanosphere Health Sciences, Llc Methods of treating inflammatory disorders and global inflammation with compositions comprising phospholipid nanoparticle encapsulations of nsaids
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
EP3389650B1 (en) 2015-12-18 2022-01-12 The Board of Regents of The University of Texas System Therapeutics for preterm labor management

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377567A (en) * 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
US4378354A (en) * 1978-12-27 1983-03-29 A. Nattermann & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
WO1983003383A1 (en) * 1982-03-29 1983-10-13 Liposome Co Inc Stable plurilamellar vesicles
DE3374914D1 (en) * 1982-04-12 1988-01-28 Univ Texas Methods and compositions for treating gastro-intestinal ulcer diesease
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
US4721612A (en) * 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes

Also Published As

Publication number Publication date
EP0249561B1 (en) 1992-05-13
DE3778972D1 (de) 1992-06-17
GR3004723T3 (forum.php) 1993-04-28
EP0249561A2 (en) 1987-12-16
EP0249561A3 (en) 1988-10-26
CA1320130C (en) 1993-07-13

Similar Documents

Publication Publication Date Title
ES2036593T3 (es) Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.
ES2145118T3 (es) Derivados de acidos grasos y composiciones farmaceuticas que los contienen.
ES2059377T3 (es) Pirazoles 1,5-diaril-3-sustituidos farmacologicamente activos y procedimiento para sintetizar los mismos.
ES479271A1 (es) Un procedimiento para la preparacion de compuestos derivados de acido tioetianico.
DOP1990004773A (es) Nueva forma del ester de cefruroxima, procedimiento para su preparacion y composicion que la coantene
ATE71834T1 (de) Liposomzubereitung und ihre herstellung.
ES2072323T3 (es) Compuestos de piperidina y su preparacion y empleo.
ES495527A0 (es) Procedimiento para la fabricacion de gamma-globulina para administracion intravenosa
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
ES2153053T3 (es) Liposomas de eter-lipido y su uso terapeutico.
IT1072444B (it) Procedimento e calandra per la preparazione di laminati plastici e simili
ES2170259T3 (es) Empleo de lipidos como agentes auxiliares en la obtencion de formas farmaceuticas solidas segun el procedimiento de extrusion en fusion.
FR2415630A1 (fr) Nouvelles 5-vinyl-2-pyrrolidones, utiles notamment dans la preparation des acides 4-amino-5-hexenoique et 4-amino-5-hexynoique, et leur preparation
MX9303123A (es) Ciclopentano-y-penteno-beta-aminoacidos, procedimiento para su preparacion y medicamentos que los contienen.
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
IT1105091B (it) Composit eterociclici della serie dell'indolo con impiego farmaceutico e procedimento per la loro produzione
IT1227456B (it) Nuovi alcossi derivati di ginkgolidi, loro preparazione e composizioni terapeutiche che li contengono
IT8021550A0 (it) Derivati adenosinici ad attivita'antinfiammatoria ed analgesica e composizioni terapeutiche che licontengono come principio attivo.
ES8502435A1 (es) Un metodo para preparar 2(1h)-piridinonas
ES2135811T3 (es) Indenoil-guanidinas sustituidas antiarritmicas y cardioprotectoras.
ES2070202T3 (es) Nuevos derivados de serina, procedimiento para su preparacion y su uso en terapia humana.
NO149352C (no) Azetidinonderivater for anvendelse som mellomprodukt ved fremstilling av farmakologisk aktive oksadetiacefalosporiner
ES2053590T3 (es) 3-fenil-7h-tiazolo(3,2-b)(1,2,4)triazin-7-onas sustituidas, procedimiento para su preparacion, medicamentos que las contienen y su empleo, asi como algunos productos intermedios formados durante la preparacion de los compuestos mencionados.
IT1113322B (it) Agente per attirare insetti composito,per i maschi della nottua del cavolo e procedimento per preparare i suoi principi attivi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 249561

Country of ref document: ES